Thirty-day readmission rates, trends and its impact on liver transplantation recipients: a national analysis.
Khalid MumtazJannel Lee-AllenKyle PorterSean KellyJames HanjeLanla F ContehAnthony J MichaelsAshraf El-HinnawiKen WashburnSylvester M BlackMarwan S AbougergiPublished in: Scientific reports (2020)
Reduction of early hospital readmissions is a declared goal in the United States economic and quality improvement agenda. A retrospective study was performed using the Nationwide Readmissions Database from 2010 to 2014. Our primary aim was to study the rate of early readmissions and its predictors in liver transplant recipients (LTRs). Our secondary aims were to determine the trends of LT, reasons for readmission, costs and predictors of calendar year mortality. Multivariable logistic regression and Cox proportional hazards models were utilized. The 30-day readmission rate was 30.6% among a total of 25,054 LTRs. Trends of LT were observed to be increased in patients > 65 years (11.7-17.8%, p < 0.001) and decreased in 40-64 years (78.0-73.5%, p = 0.001) during study period. The majority of 30-day readmissions were due to post transplant complications, with packed red blood cell transfusions being the most common intervention during readmission. Medicaid or Medicare insurance, surgery at low and medium volume centers, infections, hemodialysis, liver biopsy, and length of stay > 10 days were the predictors of 30-day readmission. Moreover, number of early readmission, age > 64 years, non-alcoholic cirrhosis, and length of stay > 10 days were significant predictor of calendar year mortality in LTRs. Approximately one third of patients require early admission after LT. Early readmission not only increases burden on healthcare, but is also associated with calendar year mortality. Strategies should be implemented to reduce readmission in patients with high risk of readmission identified in our study.
Keyphrases
- end stage renal disease
- healthcare
- chronic kidney disease
- quality improvement
- peritoneal dialysis
- newly diagnosed
- ejection fraction
- randomized controlled trial
- cardiovascular events
- emergency department
- public health
- patient safety
- coronary artery disease
- cross sectional
- health insurance
- atrial fibrillation
- adverse drug
- social media
- patient reported
- liver injury
- global health
- drug induced
- fine needle aspiration